Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Philip J. Santangelo

Select Gp120 V2 Domain Specific Antibodies Derived From HIV and SIV Infection and Vaccination Inhibit Gp120 Binding to Α4β7

PLoS Pathogens

English

Exploitation of Synthetic mRNA to Drive Immune Effector Cell Recruitment and Functional Reprogramming in Vivo

Journal of Immunology

Allergy

Immunology

2018

English

Related publications

Antibodies to the CD4-binding Site of HIV-1 Gp120 Suppress Gp120-Specific CD4 T Cell Response While Enhancing Antibody Response

Infectious Agents and Cancer

English

HIV Gp120

Science-Business eXchange

2013

English

CD4 Binding Site Antibodies Inhibit Human Immunodeficiency Virus Gp120 Envelope Glycoprotein Interaction With CCR5

English

Fusion Proteins of HIV-1 Envelope Glycoprotein Gp120 With CD4-induced Antibodies Showed Enhanced Binding to CD4 and CD4 Binding Site Antibodies

Biochemical and Biophysical Research Communications

English

Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 Gp120 and Inhibit HIV-1-induced Fusion and Entry

Journal of Biological Chemistry

English

Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 During Infection of T Lymphocytes

Virology

1996

English

Improved Induction of Antibodies Against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 Gp120 DNA Prime-Protein Boost Vaccination Compared to Gp120 Protein-Only Vaccination

English

Glycans Flanking the Hypervariable Connecting Peptide Between the a and B Strands of the V1/V2 Domain of HIV-1 Gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses

PLoS ONE

Multidisciplinary

2015

English

The Human Immunodeficiency Virus Type 1 Gp120 V2 Domain Mediates Gp41-Independent Intersubunit Contacts

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Philip J. Santangelo

Select Gp120 V2 Domain Specific Antibodies Derived From HIV and SIV Infection and Vaccination Inhibit Gp120 Binding to Α4β7

Exploitation of Synthetic mRNA to Drive Immune Effector Cell Recruitment and Functional Reprogramming in Vivo

Related publications

Antibodies to the CD4-binding Site of HIV-1 Gp120 Suppress Gp120-Specific CD4 T Cell Response While Enhancing Antibody Response

HIV Gp120

CD4 Binding Site Antibodies Inhibit Human Immunodeficiency Virus Gp120 Envelope Glycoprotein Interaction With CCR5

Fusion Proteins of HIV-1 Envelope Glycoprotein Gp120 With CD4-induced Antibodies Showed Enhanced Binding to CD4 and CD4 Binding Site Antibodies

Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 Gp120 and Inhibit HIV-1-induced Fusion and Entry

Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 During Infection of T Lymphocytes

Improved Induction of Antibodies Against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 Gp120 DNA Prime-Protein Boost Vaccination Compared to Gp120 Protein-Only Vaccination

Glycans Flanking the Hypervariable Connecting Peptide Between the a and B Strands of the V1/V2 Domain of HIV-1 Gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses

The Human Immunodeficiency Virus Type 1 Gp120 V2 Domain Mediates Gp41-Independent Intersubunit Contacts